Laparoscopic abdominosacral resection for locally advanced primary rectal cancer after treatment with mFOLFOX6 plus bevacizumab, followed by preoperative chemoradiotherapy

Asian J Endosc Surg. 2014 Jan;7(1):52-5. doi: 10.1111/ases.12068.

Abstract

Abdominosacral resection may be the only curative procedure for locally advanced rectal cancer involving the presacral fascia or sacrum. Multimodal therapy might be necessary to prevent local and distant recurrence for such tumors. A 67-year-old man was diagnosed with locally advanced rectal cancer widely involving the right pelvic sidewall and presacral fascia near the S4/5 junction on the right posterolateral side. We performed laparoscopic abdominosacral resection (S4/5) with en bloc right lateral lymph node dissection and seminal vesicle resection to obtain a clear resection margin after systemic chemotherapy with mFOLFOX6 (oxaliplatin, leucovorin, and 5-fluorouracil) plus bevacizumab, followed by preoperative chemoradiotherapy. The total operative time was 660 min, and the estimated blood loss was 550 mL. The final pathological findings revealed no residual cancer cells (pathological complete response). Laparoscopic abdominosacral resection appears to be safe and feasible in selected patients.

Keywords: Advanced rectal cancer; laparoscopic abdominosacral resection; laparoscopic surgery.

Publication types

  • Case Reports

MeSH terms

  • Abdomen / surgery*
  • Adenocarcinoma / surgery*
  • Adenocarcinoma / therapy
  • Aged
  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bevacizumab
  • Chemoradiotherapy, Adjuvant
  • Chemotherapy, Adjuvant
  • Fluorouracil / therapeutic use
  • Humans
  • Laparoscopy / methods*
  • Leucovorin / therapeutic use
  • Male
  • Neoadjuvant Therapy
  • Organoplatinum Compounds / therapeutic use
  • Rectal Neoplasms / surgery*
  • Rectal Neoplasms / therapy
  • Rectum / surgery*
  • Sacrum / surgery*

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Organoplatinum Compounds
  • Bevacizumab
  • Leucovorin
  • Fluorouracil

Supplementary concepts

  • Folfox protocol